Literature DB >> 11459811

Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.

G Fujisawa1, R Dilley, M J Fullerton, J W Funder.   

Abstract

The rapid (1-4 h) responses of epithelial target tissues to mineralocorticoids contrast with the days/weeks apparently required for responses in the cardiovascular system. The present study explores the time course and pattern of early events leading to cardiac fibrosis in the mineralocorticoid-salt rat model. Uninephrectomized rats were given deoxycorticosterone (20 mg, sc, weekly) plus 0.9% NaCl/0.3% KCl to drink and were killed at 2, 4, 8, 16, and 32 d. Type III collagen increased progressively from d 2, and blood pressure from d 4, with 4 and 8 d rats showing marked perivascular inflammatory cell infiltration. Apoptosis was also noted in perivascular areas at 4 and 8 d and in scar areas at 8, 16, and 32 d. Elevation of mineralocorticoid hormone levels inappropriate for salt status thus provokes a series of changes in cardiac vessels and myocytes leading to increased collagen deposition. When mineralocorticoid levels are elevated acutely by bolus injection, changes are discernible after 2 d, in contrast with previous infusion studies in which 3-4 wk were required for measurable changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459811     DOI: 10.1210/endo.142.8.8339

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy.

Authors:  Danos C Christodoulou; Hiroko Wakimoto; Kenji Onoue; Seda Eminaga; Joshua M Gorham; Steve R DePalma; Daniel S Herman; Polakit Teekakirikul; David A Conner; David M McKean; Andrea A Domenighetti; Anton Aboukhalil; Stephen Chang; Gyan Srivastava; Barbara McDonough; Philip L De Jager; Ju Chen; Martha L Bulyk; Jochen D Muehlschlegel; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

2.  Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.

Authors:  Vincent Chan; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.

Authors:  Volker Vallon; Amanda W Wyatt; Karin Klingel; Dan Yang Huang; Azeemudeen Hussain; Susanne Berchtold; Björn Friedrich; Florian Grahammer; Rachida S Belaiba; Agnes Görlach; Peer Wulff; Jürgen Daut; Nancy D Dalton; John Ross; Ulrich Flögel; Jürgen Schrader; Hartmut Osswald; Reinhard Kandolf; Dietmar Kuhl; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-04-08       Impact factor: 4.599

4.  Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis.

Authors:  Mryanda Sopel; Alec Falkenham; Adam Oxner; Irene Ma; Timothy D G Lee; Jean-Francois Légaré
Journal:  Int J Exp Pathol       Date:  2012-01-07       Impact factor: 1.925

5.  Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis.

Authors:  Bin Fan; Likun Ma; Qian Li; Lin Wang; Junling Zhou; Jiawei Wu
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

6.  The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress.

Authors:  Abishek Iyer; Vincent Chan; Lindsay Brown
Journal:  Curr Cardiol Rev       Date:  2010-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.